Drug Utilization Research

Methods and Applications

Monique Elseviers, Björn Wettermark, Tanja Mueller, Ria Benko, Marion Bennie, Katarina Gvozdanovic, Mikael Hoffmann, Irina Iaru, Verica Ivanovska, Sean MacBride-Stewart, Elisabetta Poluzzi, Lisa Pont, Hege Salvesen Blix, Gabriel Sanfelix-Gimeno, Gisbert Selke, Katja Taxis, Ana Tomas Petrovic, Indre Treciokiene, Sabin

• Publisher: Wiley-Blackwell
• Year: 2024
• Print ISBN: 9781119911654
• eBook ISBN: 9781119911678
• Edition: 2
• Topic: Medicine
• Subtopic: Pharmacology

Towards a better understanding of how medicines are used in society

Drug Utilization Research (DUR) is a discipline which combines aspects of pharmacotherapy, epidemiology, and health services research into an interdisciplinary set of methods for analyzing and assessing the prescribing, dispensing and consumption of medicines. It combines both qualitative and quantitative approaches to facilitate the safe and effective use of pharmaceuticals. Drug Utilization Research: Methods and Applications provides a comprehensive introduction to this discipline, prepared by an international team of authors with broad experience in numerous fields. Now reorganized and updated to reflect the latest research and global challenges, it is an indispensable resource for understanding the use of pharmaceuticals.

Readers of the second edition of Drug Utilization Research will find:

• New chapters on methods, including more hands-on guidance on how to plan and conduct different types of drug utilization
• A section on specific applications in areas such as psychotropics, opioids, cancer drugs, antibacterials, and cardiovascular drugs
• A new section with case studies illustrating applications of DUR in different continents
• Detailed treatment of subjects including DUR and health policy, DUR in specific populations, and many more

Drug Utilization Research is ideal for epidemiologists, pharmacists, physicians, nurses and others interested in drug use and its outcomes.

Table of contents

• Cover
• Title page
• Copyright
• List of Contributors
• Preface to the second edition
• Acknowledgements
• About the Companion Website
• p01
• 1 Introduction to Drug Utilization Research
• p02
• 2.1 Research Methods in Drug Utilization Research
• 2.2 Qualitative Methods in Drug Utilization Research
• 2.3 Quantitative Studies in Drug Utilization Research
• 2.4 Descriptive Studies in Drug Utilization Research
• 2.5 Analytical Studies in Drug Utilization Research
• 2.6 Intervention Studies in Drug Utilisation Research
• 2.7 Statistics in Drug Utilization Research
• 2.8 Primary Drug Utilization Data
• 2.9 Secondary Drug Utilization Data
• 2.10 Classification Systems in Drug Utilization
• 2.11 Measuring Volumes in Drug Utilization
• 2.12 Measuring Price and Expenditure in Drug Utilization
• 2.13 Aggregate-Level Drug Utilization Analyses
• 2.14 Individual-Level Drug Utilization Analyses
• 2.15 Multilevel Analyses in Drug Utilization Research
• 2.16 Visualization of Drug Utilization Data
• 2.17 Artificial Intelligence and Machine Learning in Drug Utilization Research
• 2.18 Ethics in Drug Utilization Research
• p03
• 3.1.1 Pharmaceutical Policy and Drug Utilization: Definitions, Concepts, and Taxonomies
• 3.1.2 Managed Introduction of New Medicines in Healthcare Systems
• 3.1.3 Promoting Appropriate Use of Medicines in A Healthcare System
• 3.2.1 Introduction to Comparative Drug Utilization Research
• 3.2.2 Comparison of Drug Utilization Across Countries
• 3.2.3 Comparative Drug Utilization Research Comparing Regions Within Countries
• 3.2.4 Comparison of Drug Utilization Across Different Prescribers and Different Health Care Settings
• 3.2.5 Comparative Drug Utilization Research Comparing Different Patients
• 3.3.1 Drug Utilization in Pregnant Women
• 3.3.2 Drug Utilization in the Paediatric Population
• 3.3.3 Drug Utilization in Older People
• 3.4.1 Introduction to Methodological Issues in Specific Therapeutic Areas
• 3.4.2 Drug Utilization Research on Cardiovascular Medicines
• 3.4.3 Drug Utilization Research on Antibacterials
• 3.4.4 Drugs Utilization Research in Specific Therapeutic Areas - Opioids
• 3.4.5 Drug Utilization Research on Selected Psychotropics
• 3.4.6 Drug Utilization Research in The Area of Cancer Drugs
• 3.5.1 Introduction to Medication Adherence Research
• 3.5.2 Assessment of Medication Adherence in Field Research
• 3.5.3 Assessment of Medication Adherence in Databases
• 3.5.4 Interventions to Improve Medication Adherence
• 3.5.5 Digital Tools and Medication Adherence
• 3.6.1 Risk Management and Drug Utilization Research
• 3.6.2 Pharmacovigilance and Drug Utilization Research
• 3.6.3 The Role of Drug Utilization in Outcomes Research
• 3.6.4 Pharmacoeconomics and Drug Utilization Research
• 3.6.5 The Environment and Drug Utilisation Research
• 3.7.1 Defining the Quality of Medicines Use
• 3.7.2 Assessing the Quality of Medication Use
• 3.7.3 Challenges in the Quality of Medicine Use
• 3.7.4 Development and Evaluation of Interventions to Improve the Quality of Medicine Use
• 3.7.5 Implementation of Interventions to Enhance Quality Use of Medicines
• 3.7.6 Patient Perspectives
• p04
• 4.1 Introduction to Drug Utilization Research Around the World
• 4.2 Drug Utilization Research in Africa
• 4.3 Drug Utilization Research in The Eastern Mediterranean Region
• 4.4 Drug Utilization Research in South-East Asia
• 4.5 Drug Utilization Research in The Western Pacific Region
• 4.6 Drug Utilization Research in North America
• 4.7 Drug Utilization Research in South and Central America
• 4.8 Drug Utilization Research in Europe
• 4.9 The Glasgow Declaration a Call for Improvement of the Availability and Accessibility of Drug Utilization Data
• Index
• End User License Agreement